CLINICAL TRIALS BIOMARKER TESTING

Detection covers targets including MET, HER2, EZH2, MRD, Claudin18.2, MTAP, IDH1/2, EGFR, KRAS, NTRK, FGFR, etc.

CAP & ISO 15189:2012 & CLIA CERTIFIED
Multinational Joint Laboratories, Enabling Multi-regional Clinical Trial(MRCT)